Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Peringkat dalam Saham #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Harga Saham
$0.01
Terakhir disinkronkan: 2024-08-19
Kapitalisasi Pasar
$61.27
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Alseres Pharmaceuticals, Inc. (ALSE)

Kategori

Harga ALSE dengan kapitalisasi pasar B
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
ALSE
$0.01
Kapitalisasi pasar dari Alseres Pharmaceuticals, Inc.(ALSE)
Kapitalisasi Pasar: $61.27
Per August 2026, Alseres Pharmaceuticals, Inc. memiliki kapitalisasi pasar sebesar $61.27. Ini menjadikan Alseres Pharmaceuticals, Inc. sebagai perusahaan 42806th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Alseres Pharmaceuticals, Inc. dari 1994 hingga 2026
ALSE dibandingkan dengan 5 teratas stocks paling populer
Harga ALSE Aset B Pasar B Hasil
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$885,586,506 $61.27
$5.426T +8,855,865,061,892.82%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$724,155,929 $61.27
$4.437T +7,241,559,285,096.67%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$677,229,706 $61.27
$4.149T +6,772,297,057,779.88%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$597,982,802 $61.27
$3.664T +5,979,828,016,057.99%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$471,560,223 $61.27
$2.889T +4,715,602,234,272.45%